homefeedbacksupportlog on 1-Dec-2008 
  Search
 
   
 
  Top 10s
 Rheumatology & Clinical Immunology
  Current Top 10 by F1000 Factor
  All Time Top 10 by F1000 Factor
  Most viewed Top 10
(from all journals)
  Most viewed Top 10
(from specialty journals)
  Hidden Jewels

  Sections Covered
Biomarkers of Rheumatic Disease
Bone Biology, Osteoporosis & Other Diseases of Bone
Cartilage Biology & Osteoarthritis
Clinical Immunology
Etiology, Pathogenesis & Animal Models of Rheumatic Disease
Imaging of the Musculoskeletal System
Immune & Inflammatory Rheumatic Diseases (inc. Arthritis)
Methods, measurements & outcomes in rheumatic disease
Musculoskeletal Pain & Analgesia
Musculoskeletal Repair & Regeneration
Orthopedics (inc. Sports Injuries)
Related Sections
Bone & Mineral Metabolism
Urticaria, Vasculitis & Connective Tissue Disease


 MOST VIEWED TOP 10 (from all journals) | Rheumatology & Clinical Immunology | calculated on 1 December 2008

The "Most Viewed Top 10 (from all journals)" Top 10 lists are generated every day. The articles are ordered by the number of times an article's evaluation(s) has/have been viewed over the past 30 days.

 browse faculty | show Most Viewed (all journals) Papers in

to email [Help]


1
Exceptional
F1000 Factor 9.9

Hypothesis
New Finding
 Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis.
Kain R, Exner M, …, Rees AJ, Kerjaschki D
Nat Med 2008 Oct 14(10):1088-96 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Heinz Regele / Charles Pusey with Alan Salama / Cees Kallenberg / Philippe Lesavre
First evaluation 21 Oct 2008 | Latest evaluation 17 Nov 2008
 
2
Must Read
F1000 Factor 6.5

Hypothesis
New Finding
 Innate immunity and intestinal microbiota in the development of Type 1 diabetes.
Wen L, Ley RE, …, Gordon JI, Chervonsky AV
Nature 2008 Oct 23 455(7216):1109-13 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Philipp M Lepper / Helena Tlaskalova-Hogenova / Kazuhiko Yamamoto with Akiko Okamoto
First evaluation 28 Oct 2008 | Latest evaluation 21 Nov 2008

 
3
Must Read
F1000 Factor 6.4

New Finding
 CTLA-4 control over Foxp3+ regulatory T cell function.
Wing K, Onishi Y, …, Nomura T, Sakaguchi S
Science 2008 Oct 10 322(5899):271-5 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Ann Reed with Vaidehi R Chowdhary / Gyorgy Nagy
First evaluation 31 Oct 2008 | Latest evaluation 12 Nov 2008

 
4
Must Read
F1000 Factor 6.0

Hypothesis
New Finding
 TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events.
Cavassani KA, Ishii M, …, Hogaboam CM, Kunkel SL
J Exp Med 2008 Oct 27 205(11):2609-21 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Diego Kyburz
Evaluated 20 Nov 2008

 
5
Must Read
F1000 Factor 6.0

Confirmation
Hypothesis
New Finding
 Trex1 prevents cell-intrinsic initiation of autoimmunity.
Stetson DB, Ko JS, Heidmann T, Medzhitov R
Cell 2008 Aug 22 134(4):587-98 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Roberto Caricchio with Stefania Gallucci
Evaluated 14 Nov 2008

 
6
Recommended
F1000 Factor 3.0

New Finding
 Development of regulatory T cells requires IL-7Ralpha stimulation by IL-7 or TSLP.
Mazzucchelli R, Hixon JA, …, Leonard WJ, Durum SK
Blood 2008 Oct 15 112(8):3283-92 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Javier Chinen with Usa Tantibhaedhyangkul
Evaluated 28 Oct 2008
 
7
Must Read
F1000 Factor 6.0

New Finding
 Lumican inhibits collagen deposition in tissue engineered cartilage.
Kafienah W, Cheung FL, …, Roughley PJ, Hollander AP
Matrix Biol 2008 Jul 27(6):526-34 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Rita Kandel
Evaluated 13 Nov 2008
 
8
Recommended
F1000 Factor 3.0

Confirmation
 The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: A cohort and nested case-control analysis.
Wolfe F, Michaud K
Arthritis Rheum 2008 Sep 58(9):2612-21 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Martin Aringer with Oleksandr Kleyman
Evaluated 10 Nov 2008
 
9
Must Read
F1000 Factor 6.8

New Finding
Tech Advance
 The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis.
Neubert K, Meister S, …, Manz RA, Voll RE
Nat Med 2008 Jul 14(7):748-55 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Ken Smith with Menna Clatworthy / Tak Mao Chan with S Yung / Ann Reed with Vaidehi R Chowdhary / Ulf Mueller-Ladner / Chandra Mohan with Kirthi Kumar
First evaluation 15 Jul 2008 | Latest evaluation 7 Oct 2008

 
10
Recommended
F1000 Factor 3.0

New Finding
 Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells.
Notley CA, Inglis JJ, …, McNamee KE, Williams RO
J Exp Med 2008 Oct 27 205(11):2491-7 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Carlo Chizzolini
Evaluated 30 Oct 2008

© 2008 Medicine Reports Ltd unless otherwise stated. < info@f1000.com >   Terms and conditions   Legal info